• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    CHS Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    11/6/24 12:15:25 PM ET
    $CHSCL
    Farming/Seeds/Milling
    Consumer Services
    Get the next $CHSCL alert in real time by email
    chscp-20241106
    0000823277false00008232772024-11-062024-11-060000823277chscp:A8PreferredStockMember2024-11-062024-11-060000823277chscp:ClassBSeries1PreferredStockMember2024-11-062024-11-060000823277chscp:ClassBSeries2PreferredStockMember2024-11-062024-11-060000823277chscp:ClassBSeries3PreferredStockMember2024-11-062024-11-060000823277chscp:ClassBSeries4PreferredStockMember2024-11-062024-11-06

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, DC 20549
     
    FORM 8-K
     
    CURRENT REPORT
    PURSUANT TO SECTION 13 OR 15(d) OF
    THE SECURITIES EXCHANGE ACT OF 1934
     
    Date of report (Date of earliest event reported): November 6, 2024
     
    CHS Inc.
    (Exact Name of Registrant as Specified in its Charter)
     
    Commission File Number: 001-36079
     
    Minnesota41-0251095
    (State or other jurisdiction of
    incorporation or organization)
    (I.R.S. Employer
    Identification Number)
    5500 Cenex Drive
    Inver Grove Heights,Minnesota55077
    (Address of principal executive offices, including zip code)
    (651)355-6000
    (Registrant’s telephone number, including area code)
      Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
     
    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    8% Cumulative Redeemable Preferred StockCHSCPThe Nasdaq Stock Market LLC
    Class B Cumulative Redeemable Preferred Stock, Series 1CHSCOThe Nasdaq Stock Market LLC
    Class B Reset Rate Cumulative Redeemable Preferred Stock, Series 2CHSCNThe Nasdaq Stock Market LLC
    Class B Reset Rate Cumulative Redeemable Preferred Stock, Series 3CHSCMThe Nasdaq Stock Market LLC
    Class B Cumulative Redeemable Preferred Stock, Series 4CHSCLThe Nasdaq Stock Market LLC
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐ 

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐  



    Item 2.02    Results of Operations and Financial Condition.

    On November 6, 2024, CHS Inc. issued a press release announcing its results of operations for its year ended August 31, 2024. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

    Pursuant to General Instruction B.2. to Form 8-K, the information set forth in this Item 2.02, and the exhibits to this report, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Form 8-K shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall otherwise be expressly set forth by specific reference in such filing.

    Item 9.01    Financial Statements and Exhibits.

    Exhibit No.Description
    99.1
    Press Release dated November 6, 2024
    104
    Cover Page Interactive Data File (embedded within the Inline XBRL document)







    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
      CHS Inc.
          
    Date: November 6, 2024 By: /s/ Olivia Nelligan
        Olivia Nelligan
        Executive Vice President, Chief Financial Officer and Chief Strategy Officer

    Get the next $CHSCL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CHSCL

    DatePrice TargetRatingAnalyst
    More analyst ratings